NCT06640218

Brief Summary

The aim of endodontic therapy for an inflamed tooth is to eliminate the source of inflammation. Relieving pain depends on the effectiveness of root canal therapy.3 Postoperative pain in endodontic treatments, affecting 3-58% of patients, is often caused by peri-radicular tissue injuries. Understanding these factors helps professionals select methods and supplies to minimize discomfort. 30 patients will be divided into 3 groups according to the method of activation (10 par ticipants/each). participants will be recruited from the postgrad clinic of the endodontic department faculty of oral and dental medicine, Future University in Egypt Patients with mature mandibular first permanent molar with irreversible pulpitis with apical periodontitis Intervention 1: bio-ceramic sealer activation with Eddy sonic Intervention 2: bio-ceramic sealer activation with AF max Control/Comparator: bio-ceramic sealer without activation The study aims to evaluate the effect of Eddy Sonic and AF max activation of bio-ceramic sealer on postoperative pain in mandibular first molars with symptomatic irreversible pulpitis with apical periodontitis

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
17 days until next milestone

Study Start

First participant enrolled

November 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

1 year

First QC Date

October 7, 2024

Last Update Submit

October 10, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • post-operative pain after root canal treatment with sealer activation by AF max and Eddy sonic activation in comparison to without sealer activation

    measuring post-operative pain by Numerical rate scale and pain level will be assigned to one of 4 categorical scores: None (0); Mild (1-3); Moderate (4-6); Severe (7-10).

    Immediately after obturation 6-12-24 and 48 hours post-operative

Secondary Outcomes (1)

  • Number of analgesic tablets taken after endodontic treatment

    Up to 48 hours post-operative pain

Other Outcomes (1)

  • radiographic presence or absence of sealer extrusion

    Immediately after obturation

Study Arms (3)

bio-ceramic sealer activation with Eddy sonic before obturation

ACTIVE COMPARATOR

cleaning and shaping the root canals and Well Root bio ceramic sealer activation using Eddy sonic before obturation

Device: sealer activation with Eddy sonic and AF max

bio-ceramic sealer activation with AF max before obturation

ACTIVE COMPARATOR

cleaning and shaping the root canals and Well Root bio ceramic sealer activation using AF max before obturation

Device: sealer activation with Eddy sonic and AF max

bio-ceramic sealer obturation without any activation (negative control)

ACTIVE COMPARATOR

obturation of root canals with bio ceramic sealer directly without any activation

Other: without AF max or Eddy sonic sealer activation

Interventions

activation of sealer after cleaning and shaping, before the obturation

bio-ceramic sealer activation with AF max before obturationbio-ceramic sealer activation with Eddy sonic before obturation

sealer without activation

bio-ceramic sealer obturation without any activation (negative control)

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age range is from 18 to 40 years old.
  • No sex predilection
  • Patients seeking root canal treatment.
  • restorable teeth.
  • Positive patient acceptance for participating in the study.
  • patients able to sign informed consent.
  • Systematically healthy patient (ASA I, Il).
  • Patient who can understand the numerical rate scale and sign an informed consent.
  • Mandibular first molar teeth with pain on bite or percussion
  • Preoperative sharp (moderate or severe) pain.
  • Vital response of pulp tissue to cold pulp tester (ethyl chloride spray).
  • widening in periodontal membrane space in radiographic appearance.

You may not qualify if:

  • Patients with American Association of Anesthesiologists (ASA) classifications other than ASA 1 \& Il
  • Patients who have already ingested preoperative medication, such as analgesics, non-steroidal, or steroidal anti-inflammatory drugs, within 12 hours of the start of treatment.
  • This was done to prevent any misinterpretation of the diagnosis or post-treatment pain severity, as these drugs substantially lower post-endodontic pain (Jorge-Arajo et al.,2018).
  • Patients with NSAID allergy.
  • Patients having two or more adjacent teeth needing root canal therapy
  • Pregnant patients.
  • Patients with bleeding disorder.
  • Patients with long-term corticosteroid use.
  • Teeth having:
  • Necrotic pulp.
  • History or presence of swelling or fistulous tract.
  • Acute/chronic periapical abscess.
  • Mobility more than grade 1.
  • Pocket depth of more than 5mm
  • No possible restorability.
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Future University in Egypt

Cairo, New Cairo, 11835, Egypt

RECRUITING

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 7, 2024

First Posted

October 15, 2024

Study Start

November 1, 2024

Primary Completion

November 1, 2025

Study Completion

April 1, 2026

Last Updated

October 15, 2024

Record last verified: 2024-10

Locations